The findings are notable in part because therapies have already been approved to target C5aR1 in other diseases.

Researchers are also investigating the PD-1 immune checkpoint inhibitor as treatment before surgical and radiation treatment.

While you may regularly perform checks to notice signs of skin cancer through the moles in your body, doctors say there are ...

ATOMIC Kitten’s Natasha Hamilton opened up about her skin cancer battle, revealing she was diagnosed with the disease after ...

Skin cancer is the most prevalent form of cancer globally, yet many individuals remain unaware of its subtle and often ...

Researchers have identified C5aR1 as a novel biomarker for metastasis risk and poor prognosis in patients with cutaneous ...

Be alert to subtle skin changes, as seemingly harmless spots or patches could indicate skin cancer. Skin changes are part of ...

In patients with an advanced type of skin cancer called cutaneous squamous cell carcinoma (cSCC), those who received the ...

In patients with an advanced type of skin cancer called cutaneous squamous cell carcinoma (cSCC), those who received the ...

It's the most common cancer in the US — every year, around 6 million people are treated for skin cancer, and health officials ...

Researchers have identified C5aR1 as a novel biomarker for metastasis risk and poor prognosis in patients with cutaneous ...